Rhumbline Advisers Eyenovia, Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$0.52 - $1.06 $12,058 - $24,581	-23,190 Reduced 86.19%	3,715 $2,000
Q1 2024 May 09, 2024	SELL	$0.99 - $2.37 $107 - $258	-109 Reduced 0.4%	26,905 $26,000
Q3 2023 Nov 09, 2023	BUY	$1.57 - $2.54 $4,579 - $7,409	2,917 Added 12.11%	27,014 $44,000
Q2 2023 Aug 08, 2023	BUY	$2.21 - $5.75 $53,254 - $138,557	24,097 New	24,097 $57,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $3.08M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.